Successful Vaginal Delivery After Non-Invasive Fibroid Treatment
Author Information
Author(s): Zaher S MBChB, MD, Lyons D MRCOG, Regan L FRCOG, MD
Primary Institution: Department of Academic Obstetrics and Gynaecology, Imperial College, St. Mary’s Hospital, London, United Kingdom
Hypothesis
MRgFUS may enable non-invasive treatment of uterine fibroids in women desiring pregnancy, without compromise to the integrity of the uterus or increase in pregnancy-related risks.
Conclusion
MRgFUS appears to be a safe fertility-preserving treatment option for fibroids.
Supporting Evidence
- MRgFUS is a non-invasive procedure that allows for quick recovery.
- The patient experienced significant symptom improvement after treatment.
- The patient had a successful vaginal delivery of a healthy infant.
- MRgFUS treatment did not result in complications during the procedure.
Takeaway
Doctors can use a special ultrasound treatment to help women with fibroids have babies without hurting their uterus.
Methodology
The patient underwent MRgFUS treatment for symptomatic fibroids and was monitored throughout her pregnancy.
Limitations
The study is based on a single case report and may not represent broader outcomes.
Participant Demographics
A 39-year-old woman with a history of fibroids and a previous premature delivery.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website